对乙酰氨基酚
合成代谢
接合作用
心磷脂
化学
药理学
医学
生物化学
泛素
膜
磷脂
基因
泛素连接酶
作者
Clàudia Gil‐Pitarch,Marina Serrano‐Maciá,Jorge Simón,Laura Mosca,Carolina Conter,Claudia M. Rejano-Gordillo,L. Estefanía Zapata-Pavas,Patricia Peña-Sanfélix,Mikel Azkargorta,Rubén Rodríguez‐Agudo,Sofía Lachiondo‐Ortega,Maria Mercado-Gómez,Teresa C. Delgado,Marina Porcelli,Igor Aurrekoetxea,James D. Sutherland,Rosa Barrio,Dimitris P. Xirodimas,Patricia Aspichueta,Félix Elortza
标识
DOI:10.1016/j.xcrm.2024.101653
摘要
Drug-induced liver injury (DILI) is a significant cause of acute liver failure (ALF) and liver transplantation in the Western world. Acetaminophen (APAP) overdose is a main contributor of DILI, leading to hepatocyte cell death through necrosis. Here, we identified that neddylation, an essential post-translational modification involved in the mitochondria function, was upregulated in liver biopsies from patients with APAP-induced liver injury (AILI) and in mice treated with an APAP overdose. MLN4924, an inhibitor of the neuronal precursor cell-expressed developmentally downregulated protein 8 (NEDD8)-activating enzyme (NAE-1), ameliorated necrosis and boosted liver regeneration in AILI. To understand how neddylation interferes in AILI, whole-body biotinylated NEDD8 (bioNEDD8) and ubiquitin (bioUB) transgenic mice were investigated under APAP overdose with and without MLN4924. The cytidine diphosphate diacylglycerol (CDP-DAG) synthase TAM41, responsible for producing cardiolipin essential for mitochondrial activity, was found modulated under AILI and restored its levels by inhibiting neddylation. Understanding this ubiquitin-like crosstalk in AILI is essential for developing promising targeted inhibitors for DILI treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI